These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3301452)

  • 1. Comparison of a long-acting form of propranolol and conventional propranolol in the treatment of hypertension in elderly patients.
    Khan AU
    J Int Med Res; 1987; 15(3):128-33. PubMed ID: 3301452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of Half-Inderal LA and Inderal LA in the treatment of hypertension in elderly subjects.
    Datta SR
    Br J Clin Pract; 1989 Mar; 43(3):102-8. PubMed ID: 2692687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a once daily long-acting formulation of propranolol with conventional propranolol given twice daily in patients with mild to moderate hypertension.
    Douglas-Jones AP
    J Int Med Res; 1979; 7(3):221-3. PubMed ID: 378731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily propranolol for hypertension: a comparison of regular-release, long-acting, and generic formulations.
    Carter BL; Gersema LM; Williams GO; Schabold K
    Pharmacotherapy; 1989; 9(1):17-22. PubMed ID: 2646619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single dose administration of propranolol in hypertension: a comparison of two formulations using clinic and home blood pressure measurements.
    Vandongen R; Beilin LJ; Lalor C; Wall BP
    Aust N Z J Med; 1982 Oct; 12(5):473-7. PubMed ID: 6758744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
    Bochsler JA; Simmons RL; Ward PJ; Chester PC; Latham AN
    J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-acting propranolol on blood pressure and heart rate in hypertensive Chinese.
    Oh VM; Chia BL; Taylor EA
    Br J Clin Pharmacol; 1985 Aug; 20(2):144-7. PubMed ID: 4041332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter comparison of the nifedipine gastrointestinal therapeutic system and long-acting propranolol in patients with mild to moderate systemic hypertension receiving diuretics. A preliminary experience.
    Frishman WH; Garofalo JL; Rothschild A; Rothschild M; Greenberg SM; Soberman J
    Am J Med; 1987 Dec; 83(6B):15-9. PubMed ID: 3332574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol in cardiac arrhythmias: a comparative study of the conventional and long-acting formulations.
    Kubik MM; Gill B; Dawes PM
    Curr Med Res Opin; 1986; 10(4):215-20. PubMed ID: 3780285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twice-daily verapamil for hypertension: a comparison with propranolol.
    Hornung RS; Jones RI; Gould BA; Sonecha T; Raftery EB
    Am J Cardiol; 1986 Feb; 57(7):93D-98D. PubMed ID: 3513519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of long-acting propranolol and conventional metoprolol in the treatment of hypertension.
    Jäättelä A; Mäki O
    Ann Clin Res; 1983 Apr; 15(2):45-9. PubMed ID: 6349512
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol.
    Garg DC; Jallad NS; Mishriki A; Chalavarya G; Kraml M; Fencik M; Weidler DJ
    J Clin Pharmacol; 1987; 27(5):390-6. PubMed ID: 3693583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the effectiveness of delayed-action propranolol in the treatment of arterial hypertension].
    Markiewicz M; Koziara Z; Wysokiński A; Lakomski B
    Wiad Lek; 1992 Apr; 45(7-8):243-7. PubMed ID: 1462581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparison of indoramin and propranolol in the treatment of moderate to severe essential hypertension.
    Antani J; Buckle JW; Turner J; Cohen M
    Curr Med Res Opin; 1983; 8(9):603-11. PubMed ID: 6365463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol and propranolol-LA in essential tremor: a double blind comparative study.
    Cleeves L; Findley LJ
    J Neurol Neurosurg Psychiatry; 1988 Mar; 51(3):379-84. PubMed ID: 3283296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol LA and ambulatory blood pressure.
    Mann S; Craig MW; Balasubramanian V; Raftery EB
    Br J Clin Pharmacol; 1980 Nov; 10(5):443-7. PubMed ID: 7437256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol in patients with moderate hypertension.
    Serlin MJ; Orme ML; MacIver M; Green GJ; Sibeon RG; Breckenridge AM
    Br J Clin Pharmacol; 1983 May; 15(5):519-27. PubMed ID: 6860527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol in angina pectoris. Comparison of long-acting and standard-formulation propranolol.
    Parker JO; Porter A; Parker JD
    Circulation; 1982 Jun; 65(7):1351-5. PubMed ID: 6804113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension.
    Petrie JC; Jeffers TA; Robb OJ; Scott AK; Webster J
    Br Med J; 1980 Jun; 280(6231):1573-4. PubMed ID: 7000243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single daily dose penbutolol in the treatment of hypertension: a double blind crossover comparison with propranolol.
    Kubik MM; Hanks GW
    Eur J Clin Pharmacol; 1980 Jun; 17(6):409-13. PubMed ID: 6995132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.